The extracellular matrix as a multitasking player in disease

AD Theocharis, D Manou, NK Karamanos - The FEBS journal, 2019 - Wiley Online Library
Extracellular matrices (ECM s) are highly specialized and dynamic three‐dimensional (3D)
scaffolds into which cells reside in tissues. ECM is composed of a variety of fibrillar …

Mesenchymal stem cells: amazing remedies for bone and cartilage defects

P Kangari, T Talaei-Khozani… - Stem Cell Research & …, 2020 - Springer
Skeletal disorders are among the leading debilitating factors affecting millions of people
worldwide. The use of stem cells for tissue repair has raised many promises in various …

Management of endocrine disease: Osteogenesis imperfecta: An update on clinical features and therapies

R Marom, BM Rabenhorst… - European journal of …, 2020 - academic.oup.com
Osteogenesis imperfecta (OI) is an inherited skeletal dysplasia characterized by bone
fragility and skeletal deformities. While the majority of cases are associated with pathogenic …

Into the tissues: Extracellular matrix and its artificial substitutes: Cell signalling mechanisms

A Bandzerewicz, A Gadomska-Gajadhur - Cells, 2022 - mdpi.com
The existence of orderly structures, such as tissues and organs is made possible by cell
adhesion, ie, the process by which cells attach to neighbouring cells and a supporting …

Osteogenesis imperfecta: advancements in genetics and treatment

V Rossi, B Lee, R Marom - Current opinion in pediatrics, 2019 - journals.lww.com
Osteogenesis imperfecta is a skeletal dysplasia characterized by bone fragility and
extraskeletal manifestations. Better understanding of the mechanisms of osteogenesis …

Type I collagen

K Henriksen, MA Karsdal - Biochemistry of collagens, laminins and elastin, 2024 - Elsevier
In bone, skin, and connective tissues, type I collagen is not only the most abundant collagen,
but it is also essential for tissue integrity. Type I collagen is an interstitial matrix molecule that …

Osteogenesis imperfecta: new perspectives from clinical and translational research

JT Tauer, ME Robinson, F Rauch - Journal of Bone and Mineral …, 2019 - academic.oup.com
Osteogenesis imperfecta (OI) is a monogenic bone fragility disorder that usually is caused
by mutations in one of the two genes coding for collagen type I alpha chains, COL1A1 or …

Dissecting the role of hyaluronan synthases in the tumor microenvironment

A Passi, D Vigetti, S Buraschi, RV Iozzo - The FEBS journal, 2019 - Wiley Online Library
The tumor microenvironment is becoming a crucial factor in determining the aggressiveness
of neoplastic cells. The glycosaminoglycan hyaluronan is one of the principal constituents of …

Osteogenesis imperfecta: current and prospective therapies

M Botor, A Fus-Kujawa, M Uroczynska, KL Stepien… - Biomolecules, 2021 - mdpi.com
Osteogenesis Imperfecta (OI) is a group of connective tissue disorders with a broad range of
phenotypes characterized primarily by bone fragility. The prevalence of OI ranges from …

Deciphering the relevance of bone ECM signaling

N Alcorta-Sevillano, I Macías, A Infante, CI Rodríguez - Cells, 2020 - mdpi.com
Bone mineral density, a bone matrix parameter frequently used to predict fracture risk, is not
the only one to affect bone fragility. Other factors, including the extracellular matrix (ECM) …